These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38057118)

  • 81. Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study.
    Galambosi PJ; Kaaja RJ; Stefanovic V; Ulander VM
    Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):154-9. PubMed ID: 22658765
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Secondary recurrent miscarriage is associated with previous male birth.
    Ooi PV; Russell N; O'Donoghue K
    J Reprod Immunol; 2011 Jan; 88(1):38-41. PubMed ID: 21129780
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth.
    Kolanska K; Dabi Y; Dechartres A; Cohen J; Ben Kraiem Y; Selleret L; Mathieu d'Argent E; Placais L; Cheloufi M; Johanet C; Rosefort A; Bornes M; Suner L; Delhommeau F; Ledée N; Chabbert Buffet N; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
    Am J Reprod Immunol; 2021 Aug; 86(2):e13425. PubMed ID: 33772927
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
    Thachil J
    Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Administration of low-molecular-weight heparin in patients with two or more unsuccessful IVF/ICSI cycles: a multicenter cohort study.
    Siristatidis C; Dafopoulos K; Salamalekis G; Galazios G; Christoforidis N; Moustakarias T; Koutlaki N; Bouschanetzis C; Loutradis D; Drakakis P
    Gynecol Endocrinol; 2018 Sep; 34(9):747-751. PubMed ID: 29465258
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Low-molecular-weight heparin in thrombophilic women receiving in vitro fertilization/intracytoplasmic sperm injection: A meta-analysis.
    Chen J; Bie J; Jiang F; Wu Y; Pan Z; Meng Y; Song J; Liu Y
    Acta Obstet Gynecol Scand; 2023 Nov; 102(11):1431-1439. PubMed ID: 37475190
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: A systematic review and meta-analysis.
    Chen Y; Wang T; Liu X; Ye C; Xing D; Wu R; Li F; Chen L
    J Obstet Gynaecol Res; 2022 Aug; 48(8):2134-2150. PubMed ID: 35661489
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Meta-Analysis of the Efficacy of Low Molecular Weight Heparin and Aspirin in the Treatment of Thrombosis During Pregnancy and Effects on Coagulation Function.
    Yin M; Qin X
    Discov Med; 2023 Apr; 35(175):104-115. PubMed ID: 37105921
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
    Lin PT; Wang SH; Chi CC
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treating unexplained recurrent pregnancy loss based on lessons learned from obstetric antiphospholipid syndrome and inherited thrombophilia: A propensity-score adjusted retrospective study.
    Scarrone M; Canti V; Vanni VS; Bordoli S; Pasi F; Quaranta L; Erra R; De Lorenzo R; Rosa S; Castiglioni MT; Candiani M; Rovere-Querini P
    J Reprod Immunol; 2022 Dec; 154():103760. PubMed ID: 36395545
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical characteristics of pregnancies with a history of recurrent miscarriage at a Japanese perinatal center.
    Terada K; Nakanishi K; Suzuki S
    J Nippon Med Sch; 2015; 82(1):36-8. PubMed ID: 25797873
    [TBL] [Abstract][Full Text] [Related]  

  • 94. New studies of low-molecular-weight heparin in pregnancy.
    Middeldorp S
    Thromb Res; 2015 Feb; 135 Suppl 1():S26-9. PubMed ID: 25903529
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Role of low-molecular-weight heparin in altering uterine artery blood flow in recurrent spontaneous abortion: a prospective study.
    Zhang K; Wang E; Li Y; Xu H; Zhang J; Wang X; Shu J
    J Int Med Res; 2020 Aug; 48(8):300060520945558. PubMed ID: 32780610
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 97. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.
    Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Atik RB; Bloemenkamp KW; Brady R; Briley A; Cavallaro R; Cheong YC; Chu J; Eapen A; Essex H; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Parrott S; Ross JA; Sharpe L; Stewart J; Trépel D; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
    Health Technol Assess; 2016 May; 20(41):1-92. PubMed ID: 27225013
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
    Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?
    Kalk JJ; Huisjes AJ; de Groot CJ; van Beek E; van Pampus MG; Spaanderman ME; van Eyck J; Oei SG; Bezemer PD; de Vries JI
    Neth J Med; 2004 Mar; 62(3):83-7. PubMed ID: 15209472
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region.
    Moretti G; Vinci B; Zito S; Caputo A; Attanasio F; Vainieri M
    PLoS One; 2023; 18(9):e0291628. PubMed ID: 37708187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.